Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates

Core Insights - Elanco Animal Health Incorporated (ELAN) reported quarterly earnings of $0.19 per share, exceeding the Zacks Consensus Estimate of $0.13 per share, and showing an increase from $0.13 per share a year ago, resulting in an earnings surprise of +46.15% [1] - The company achieved revenues of $1.14 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.28%, compared to $1.03 billion in the same quarter last year [2] - Elanco Animal Health shares have increased approximately 85.8% since the beginning of the year, significantly outperforming the S&P 500's gain of 15.1% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.13 on revenues of $1.08 billion, and for the current fiscal year, it is $0.89 on revenues of $4.6 billion [7] Industry Context - The Medical - Outpatient and Home Healthcare industry, to which Elanco belongs, is currently ranked in the top 18% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]